Vermont Business Magazine A longtime Emergency Department (ED) physician and clinical leader at University of Vermont Health ...

The ADAMHS Board, The Centers, and Cuyahoga County are collaborating to establish a behavioral health crisis receiving center ...

Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.

Hosted by the Tulane University Center for Continuing Education, seminar brings together leading researchers and clinicians ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

We are collecting data on people who have sought ibogaine treatment all around the world so we can start to collect a very ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The replacement of safe consumption sites with Homelessness and Addiction Recovery Treatment Hubs is dangerous and lacks a ...

Rahul Gupta reflects on the status of the war on drugs as he steps down as head of the Office of National Drug Control Policy.